Skip to main content
SpringerLink
Log in

Neurological Aspects of Caring for the Aged

  • Chapter
Aging, Heart Disease, and Its Management

Part of the book series: Contemporary Cardiology ((CONCARD))

  • 126 Accesses

Abstract

The human brain changes as it ages, and the elderly are increasingly susceptible to many neurological diseases and symptoms. Neurological disorders are the leading source of serious disability among the elderly and one of the major reasons for institutionalization of elderly individuals. As many as 90% of institutionalized elderly persons have disabilities caused by neurological disease, and as many as 50% of the elderly living in the community have neurological problems. This burden of age-related neurological disease in the population is only expected to increase as the population ages.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Creasey H, Rapoport SI. The aging human brain. Ann Neurol 1985; 17: 2 - 10.

    Article  PubMed  CAS  Google Scholar 

  2. Esri MM, Hyman BT, Beyreuther K, et al. Ageing and the dementias. In: Graham DI, Lantos PL, eds. Greenfield’s Neuropathology, 6th ed. Oxford University Press, New York, 1997, vol 1, pp. 153 - 233.

    Google Scholar 

  3. Masliah E, Mallory M, Hansen L, et al. Quantitative synaptic alterations in the human neocortex during normal aging. Neurology 1993; 43: 192 - 197.

    Article  PubMed  CAS  Google Scholar 

  4. Schochet SS. Neuropathology of aging. Neurol Clin 1998; 16: 569 - 580.

    Article  PubMed  Google Scholar 

  5. Pantoni L, Garcia JH. The significance of cerebral white matter abnormalities 100 years after Binswanger’s report: a review. Stroke 1995; 26: 1293 - 1301.

    Article  PubMed  CAS  Google Scholar 

  6. Ketonen LM. Neuroimaging of the aging brain. Neurol Clin 1998; 16: 581 - 598.

    Article  PubMed  CAS  Google Scholar 

  7. Fazekas F. Magnetic resonance signal abnormalities in asymptomatic individuals: their incidence and functional correlates. Eur Neurol 1989; 29: 164 - 168.

    Article  PubMed  CAS  Google Scholar 

  8. Awad I, Johnson P, Spetzler R, et al. Incidental subcortical lesions identified on magnetic resonance imaging in the elderly. I. Postmortem pathological correlation. Stroke 1986; 17: 1090 - 1097.

    Article  PubMed  CAS  Google Scholar 

  9. Yue NC, Arnold AM, Longstreth WT, et al. Sulcal, ventricular, and white matter changes at MR imaging in the aging brain: data from the cardiovascular health study. Radiology 1997; 202: 33 - 39.

    PubMed  CAS  Google Scholar 

  10. Coffey CE, Wilkinson WE, Parashos IA, et al. Quantitative cerebral anatomy of the aging human brain: a cross-sectional study using magnetic resonance imaging. Neurology 1992; 42: 527 - 536.

    Article  PubMed  CAS  Google Scholar 

  11. Jernigan T, Archibald S, Berhow M, et al. Cerebral structure on MRI, part I: localization of age-related changes. Biol Psychiatry 1991; 29: 55 - 67.

    Article  PubMed  CAS  Google Scholar 

  12. Cowell PE, Turetskky BI, Gur RC, et al. Sex differences in aging of the human frontal and temporal lobes. J Neurosci 1994; 14: 4748 - 4755.

    PubMed  CAS  Google Scholar 

  13. Eberling JL, Nordahl TE, Kusubov N, et al. Reduced temporal lobe glucose metabolism in aging. J Neuro-imaging 1995; 5: 178 - 182.

    CAS  Google Scholar 

  14. Shigeta M, Julin P, Almkvist O, et al. EEG in successful aging: a 5 year follow-up study from the eighth to ninth decade of life. Electroencephal Clin Neurophysiol 1995; 95: 77 - 83.

    Article  CAS  Google Scholar 

  15. Albert MS. Predictors of cognitive change in older persons: MacArthur studies of successful aging. Psychol Aging 1995; 10: 578 - 589.

    CAS  Google Scholar 

  16. Petersen RC, Stevens JC, Ganguli M, Tangalos EG, Cummings JL, DeKosky ST. Practice parameter: early detection of dementia: mild cognitive impairment (an evidence-based review): Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2001; 56: 1133 - 1142.

    Article  PubMed  CAS  Google Scholar 

  17. Keefover RW. Aging and cognition. Neurol Clin 1998; 16: 635 - 648.

    Article  PubMed  CAS  Google Scholar 

  18. Knopman DS, DeKosky ST, Cummings JL, Chui H, Corey-Bloom J, Relkin N, et al. Practice parameter: diagnosis of dementia (an evidence-based review): Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2001; 56: 1143 - 1153.

    Article  PubMed  CAS  Google Scholar 

  19. Doody RS, Stevens JC, Beck C, Dubinsky RM, Kaye JA, Gwyther L, et al. Practice parameter: management of dementia (an evidence-based review): Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2001; 56: 1154 - 1166.

    Article  PubMed  CAS  Google Scholar 

  20. Petersen RC, Smith GE, Waring SC, et al. Mild cognitive impairment: clinical characterization and outcome. Arch Neurol 1999; 56: 303 - 308.

    Article  PubMed  CAS  Google Scholar 

  21. Perls TT, Morris JN, Ooi WL, et al. The relationship between age, gender, and cognitive performance in the very old: the effect of selective survival. J Am Geriatr Soc 1993; 41: 1193 - 1201.

    PubMed  CAS  Google Scholar 

  22. Van Duijn C, Clayton D, Chandra V, et al. Familial aggregation of Alzheimer’s disease and related disorders: a collaborative re-analysis of case control studies. Int J Epidemiol 1991; 20 (Suppl): 13 - 20.

    Article  Google Scholar 

  23. Mortimer J, van Duijn C, Chandra V, et al. Head trauma as a risk factor for Alzheimer’s disease: a collaborative re-analysis of case control studies. Int J Epidemiol 1991; 20 (Suppl): 28 - 35.

    Google Scholar 

  24. Stern Y, Gurland B, Tatemichi T, et al. Influence of education and occupation on the incidence of Alzheimer’s disease. JAMA 1994; 271: 1004 - 1010.

    Article  PubMed  CAS  Google Scholar 

  25. Chui H, Zhang Q. Evaluation of dementia: a systematic study of the usefulness of the American Academy of Neurology’s practice parameters. Neurology 1997; 49: 925 - 935.

    Article  PubMed  CAS  Google Scholar 

  26. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry 1960; 23: 56 - 62.

    Article  PubMed  CAS  Google Scholar 

  27. Burke WJ, Roccaforte WH, Wengel SP. The short form of the Geriatric Depression Scale: a comparison with the 30-item form. J Geriatr Psychiatry Neurol 1991; 4: 173 - 178.

    Article  PubMed  CAS  Google Scholar 

  28. Holmes C, Cairns N, Lantos P, et al. Validity of current clinical criteria for Alzheimer’s disease, vascular dementia and dementia with Lewy bodies. Br J Psychiatry 1999; 174: 45 - 50.

    Article  PubMed  CAS  Google Scholar 

  29. Lim A, Tsuang D, Kukull W, et al. Clinico-neuropathological correlation of Alzheimer’s disease in a community-based case series. J Am Geriatr Soc 1999; 47: 564 - 569.

    PubMed  CAS  Google Scholar 

  30. Desmond DW, Moroney JT, Paik MC, Sano M, Mohr JP, Aboumatar S, et al. Frequency and clinical determinants of dementia after ischemic stroke. Neurology 2000; 54: 1124 - 1131.

    Article  PubMed  CAS  Google Scholar 

  31. Hsich G, Kenney K, Gibbs CJ, et al. The 14-3-3 brain protein in cerebrospinal fluid as a marker for transmissible spongiform encephalopathies. N Engl J Med 1996; 335: 924 - 930.

    Article  PubMed  CAS  Google Scholar 

  32. Knapp M, Knopman D, Solomon P, et al., for the Tacrine Study Group. A 30-week randomized controlled trial of high-dose tacrine in patients with Alzheimer’s disease. JAMA 1994; 271: 985 - 991.

    Article  PubMed  CAS  Google Scholar 

  33. Watkins P, Zimmerman H, Knapp M, et al. Hepatotoxic effects of tacrine administration in patients with Alzheimer’s disease. JAMA 1994; 271: 992 - 998.

    Article  PubMed  CAS  Google Scholar 

  34. Davis K, Thal L, Gamzu E, et al. A double-blind, placebo-controlled multicenter study of tacrine for Alzheimer’s disease. N Engl J Med 1992; 327: 1253 - 1259.

    Article  PubMed  CAS  Google Scholar 

  35. Rogers S, Doody R, Mohs R, et al., and the Donepezil Study Group. Donepezil improved cognition and global function in Alzheimer’s disease. Arch Intern Med 1998; 158: 1021 - 1031.

    Article  PubMed  CAS  Google Scholar 

  36. Rogers S, Farlow M, Doody R, et al., and the Donepezil Study Group. A 24-week, double-blind, placebo-controlled trial of donepezil in patients with Alzheimer’ s disease. Neurology 1998; 50: 136 - 145.

    Article  PubMed  CAS  Google Scholar 

  37. Forette F, Anand R, Gharabawi G. A phase II study in patients with Alzheimer’s disease to assess the preliminary efficacy and maximum tolerated dose of rivastigmine (Exeloninfinity). Eur J Neurol 1999; 6: 423 - 429.

    Article  PubMed  CAS  Google Scholar 

  38. RoslerM, Anand R, Cicin-Sain A, et al. Efficacy and safety of rivastigmine in patients with Alzheimer’s disease: international randomised controlled trial. Br Med J 1999; 318: 633 - 638.

    Google Scholar 

  39. Raskind M, Peskind E, Wessel T, et al., and the Galantamine Study Group. Galantamine in AD. A 6-month randomized, placebo-controlled trial with a 6-month extension. Neurology 2000; 54: 2261 - 2268.

    Article  PubMed  CAS  Google Scholar 

  40. Tariot P, Solomon P, Morris J, et al., and the Galantamine Study Group. A 5-month, randomized, placebo-controlled trial of galantamine in AD. Neurology 2000; 54: 2269 - 2276.

    Article  PubMed  CAS  Google Scholar 

  41. Sano M, Ernesto C, Thomas RG, et al. A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer’s disease. N Engl J Med 1997; 336: 1216 - 1222.

    Article  PubMed  CAS  Google Scholar 

  42. t Veld BA, Ruitenberg A, Hofman A, Launer LJ, van Duijn CM, Stijnen T, et al. Nonsteroidal antiinflammatory drugs and the risk of Alzheimer’s disease. N Engl J Med 2001; 345: 1515 - 1521.

    Article  Google Scholar 

  43. De Deyn P, Rabheru K, Rasmussen A, et al. A randomized trial of risperidone, placebo, and haloperidol for behavioral symptoms of dementia. Neurology 1999; 53: 946 - 955.

    Article  PubMed  Google Scholar 

  44. Mayeux R, Sano M. Drug therapy: treatment of Alzheimer’s disease. N Engl J Med 1999; 341: 1670 1679.

    Google Scholar 

  45. Moroney JT, Tang MX, Berglund L, Small S, Merchant C, Bell K, et al. Low-density lipoprotein cholesterol and the risk of dementia with stroke. JAMA 1999; 282 (3): 254 - 260.

    Article  PubMed  CAS  Google Scholar 

  46. Broderick J, Brott T, Kothari R, Miller R, Khoury J, Pancioli A, et al. The Greater Cincinnati/Northern Kentucky Stroke Study. Preliminary first-ever and total incidence rates of stroke among blacks. Stroke 1998; 29: 415 - 421.

    Article  PubMed  CAS  Google Scholar 

  47. Aho K, Harmsen P, Hatano S, Marquardsen J, Smirnov WE, Strasser T. Cerebrovascular disease in the community: results of a WHO collaborative study. Bull WHO 1980; 58: 113 - 130.

    PubMed  CAS  Google Scholar 

  48. Kidwell CS, Alger JR, Di Salle F, Starkman S, Villablanca P, Bentson J, et al. Diffusion MRI in patients with transient ischemic attacks. Stroke 1999; 30 (6): 1174 - 1180.

    Article  PubMed  CAS  Google Scholar 

  49. Sacco RL. Lobar intracerebral hemorrhage. N Engl J Med 2000; 342: 276 - 279.

    Article  PubMed  CAS  Google Scholar 

  50. O’Donnell HC, Rosand J, Knudsen KA, Furie KL, Segal AZ, Chiu RI, et al. Apolipoprotein E genotype and the risk of recurrent lobar intracerebral hemorrhage. N Engl J Med 2000; 342: 240 - 245.

    Google Scholar 

  51. Greenberg SM, O’Donnell HC, Schaefer PW, Kraft E. MRI detection of new hemorrhages: potential marker of progression in cerebral amyloid angiopathy. Neurology 1999; 53: 1135 - 1138.

    Article  PubMed  CAS  Google Scholar 

  52. Greenberg SM, Vonsattel JP, Stakes JW, Gruber M, Finklestein SP. The clinical spectrum of cerebral amyloid angiopathy: presentations without lobar hemorrhage. Neurology 1993; 43: 2073 - 2079.

    Article  PubMed  CAS  Google Scholar 

  53. Sacco RL, Ellenberg JH, Mohr JP, Tatemichi TK, Hier DB, Price TR, et al. Infarcts of undetermined cause: the NINCDS Stroke Data Bank. Ann Neurol 1989; 25: 382 - 390.

    Article  PubMed  CAS  Google Scholar 

  54. Adams HP Jr, Brott TG, Crowell RM, Furlan AJ, Gomez CR, Grotta J, et al. Guidelines for the management of patients with acute ischemic stroke. A statement for healthcare professionals from a special writing group of the Stroke Council, American Heart Association. Stroke 1994; 25: 1901 - 1914.

    Article  PubMed  Google Scholar 

  55. Feinberg WM, Albers GW, Barnett HJ, Biller J, Caplan LR, Carter LP, et al. Guidelines for the management of transient ischemic attacks. From the Ad Hoc Committee on Guidelines for the Management of Transient Ischemic Attacks of the Stroke Council of the American Heart Association. Stroke 1994; 25: 1320 - 1335.

    Article  Google Scholar 

  56. Brown RD, Whisnant JP, Sicks RD, O’Fallon WM, Wiebers DO. Stroke incidence, prevalence, and survival: secular trends in Rochester, Minnesota, through 1989. Stroke 1996; 27: 373 - 380.

    PubMed  CAS  Google Scholar 

  57. Wolf PA, D’Agostino RB, O’Neal MA, Sytkowski P, Kase CS, Belanger AJ, et al. Secular trends in stroke incidence and mortality: the Framingham Study. Stroke 1992; 23: 1551 - 1555.

    Article  PubMed  CAS  Google Scholar 

  58. Sacco RL, Boden-Albala B, Gan R, Chen X, Kargman DE, Shea S, et al. Stroke incidence among white, black, and Hispanic residents of an urban community: the Northern Manhattan Stroke Study. Am J Epidemiol 1998; 147: 259 - 268.

    Article  PubMed  CAS  Google Scholar 

  59. Howard G, Anderson R, Sorlie P, Andrews V, Backlund E, Burke GL. Ethnic differences in stroke mortality between non-Hispanic whites, Hispanic whites, and blacks: the National Longitudinal Mortality Study. Stroke 1994; 25: 2120 - 2125.

    Article  PubMed  CAS  Google Scholar 

  60. Giles WH, Kittner SJ, Hebel JR, Losonczy KG, Sherwin RW. Determinants of black-white differences in the risk of cerebral infarction. Arch Intern Med 1995; 155: 1319 - 1324.

    Article  PubMed  CAS  Google Scholar 

  61. MacMahon S, Rodgers A. Blood pressure, antihypertensive treatment and stroke risk. J Hypertens 1994; 12 (Suppl 10): S5 - S14.

    CAS  Google Scholar 

  62. Laupacis A, Albers G, Dalen J, Dunn MI, Jacobson AK, Singer DE. Antithrombotic therapy in atrial fibrillation. Chest 1998; 114: 579S - 589S.

    Article  PubMed  CAS  Google Scholar 

  63. Shepherd J, Cobbe SM, Ford I, et al. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. N Engl J Med 1995; 333: 1301 - 1307.

    Article  PubMed  CAS  Google Scholar 

  64. The Heart Outcomes Prevention Evaluation Study Investigators. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. N Engl J Med 2000; 342: 145 - 153.

    Article  Google Scholar 

  65. UK Prospective Diabetes Study (UKPDS) Group. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). Lancet 1998; 352: 854 - 865.

    Article  Google Scholar 

  66. Executive Committee for the Asymptomatic Carotid Atherosclerosis Study. Endarterectomy for asymptomatic carotid artery stenosis. JAMA 1995; 273: 1421 - 1428.

    Article  Google Scholar 

  67. PROGRESS Collaborative Group. Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6105 individuals with previous stroke or transient ischaemic attack. Lancet 2001; 358: 1033 - 1041.

    Article  Google Scholar 

  68. North American Symptomatic Carotid Endarterectomy Trial Collaborators. Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade carotid stenosis. N Engl J Med 1991; 325: 445 - 453.

    Article  Google Scholar 

  69. Endovascular versus surgical treatment in patients with carotid stenosis in the Carotid and Vertebral Artery Transluminal Angioplasty Study (CAVATAS): a randomised trial. Lancet 2001;357:1729-1737.

    Google Scholar 

  70. Sacco RL. Extracranial carotid stenosis. N Engl J Med 2001; 345: 1113 - 1118.

    Article  PubMed  CAS  Google Scholar 

  71. The Canadian Cooperative Study Group. A randomized trial of aspirin and sulfinpyrazone in threatened stroke. N Engl J Med 1978; 299: 53 - 59.

    Article  Google Scholar 

  72. The SALT Collaborative Group. Swedish Aspirin Low-dose Trial (SALT) of 75 mg aspirin as secondary prophylaxis after cerebrovascular ischemic events. Lancet 1991; 338: 1345 - 1349.

    Article  Google Scholar 

  73. Farrell B, Godwin J, Richards S, Warlow C. The United Kingdom Transient Ischaemic Attack (UKTIA) Aspirin Trial: final results. J Neurol Neurosurg Psychiatry 1991; 54: 1044 - 1054.

    Article  PubMed  CAS  Google Scholar 

  74. Antiplatelet Trialists’ Collaboration. Collaborative overview of randomised trials of antiplatelet therapy -I: prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. Br Med J 1994; 308: 81 - 106.

    Article  Google Scholar 

  75. The Dutch TIA Trial Study Group. A comparison of two doses of aspirin (30 mg vs. 283 mg a day) in patients after a transient ischemic attack or minor ischemic stroke. N Engl J Med 1991; 325: 1261 - 1266.

    Article  Google Scholar 

  76. Diener HC, Cunha L, Forbes C, et al. European Stroke Prevention Study 2. Dipyridamole and acetylsalicylic acid in the secondary prevention of stroke. J Neurolog Sci 1996; 143: 1 - 13.

    Article  CAS  Google Scholar 

  77. Gent M, Blakely JA, Easton JD, Ellis DJ, Hachinski VC, Harbison JW, et al. The Canadian American Ticlopidine Study (CATS) in thromboembolic stroke. Lancet 1989;i:1215-1220.

    Google Scholar 

  78. Hass WK, Easton JD, Adams HP Jr, Pryse-Phillips W, Molony BA, Anderson S, et al. A randomized trial comparing ticlopidine hydrochloride with aspirin for the prevention of stroke in high-risk patients. N Engl J Med 1989; 321: 501 - 507.

    Article  PubMed  CAS  Google Scholar 

  79. CAPRIE Steering Committee. A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). Lancet 1996; 348: 1329 - 1339.

    Article  Google Scholar 

  80. Bennett CL, Connors JM, Carwile JM, Moake JL, Bell WR, Tarantolo SR, et al. Thrombotic thrombocytopenic purpura associated with clopidogrel. N Engl J Med 2000; 342: 1773 - 1777.

    Article  PubMed  CAS  Google Scholar 

  81. Mohr JP, Thompson JLP, Lazar RM, Levin B, Sacco RL, Furie KL, et al., for the Warfarin-Aspirin Recurrent Stroke Study Group. A comparison of warfarin and aspirin for the prevention of recurrent ischemic stroke. N Engl J Med 2001; 345: 1444 - 1451.

    Article  PubMed  CAS  Google Scholar 

  82. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 1995; 333: 1581 - 1587.

    Article  Google Scholar 

  83. Marler JR, Tilley BC, Lu M, Brott TG, Lyden PC, Grotta JC, et al. Early stroke treatment associated with better outcome: the NINDS rt-PA stroke study. Neurology 2000; 55: 1649 - 1655.

    Article  PubMed  CAS  Google Scholar 

  84. Rordorf G, Koroshetz WJ, Ezzeddine MA, Segal AZ, Buonanno FS. A pilot study of drug-induced hypertension for treatment of acute stroke. Neurology 2001; 56: 1210 - 1213.

    Article  PubMed  CAS  Google Scholar 

  85. Gardner TJ, Horneffer PJ, Manolio TA, et al. Stroke following coronary artery bypass grafting: a ten-year study. Ann Thorac Surg 1985; 40: 574 - 581.

    Article  PubMed  CAS  Google Scholar 

  86. Coffey CE, Massey EW, Roberts KB, Curtis S, Jones RH, Pryor DB. Natural history of cerebral complications of coronary artery bypass graft surgery. Neurology 1983; 33: 1416 - 1421.

    Article  PubMed  CAS  Google Scholar 

  87. Breuer AC, Furlan AJ, Hanson MR, et al. Central nervous system complications of coronary artery bypass graft surgery: prospective analysis of 421 patients. Stroke 1983; 14: 682 - 687.

    Article  PubMed  CAS  Google Scholar 

  88. McKhann GM, Goldsborough MA, Borowicz LM, Mellits ED, Brookmeyer R, Quaskey SA, et al. Predictors of stroke risk in coronary artery bypass patients. Ann Thorac Surg 1997; 63: 516 - 521.

    Article  PubMed  CAS  Google Scholar 

  89. Parker FB, Marvasti MA, Bove EL. Neurological complications following coronary artery bypass. The role of atherosclerotic emboli. Thorac Cardiovasc Surg 1985; 33: 207 - 209.

    Article  PubMed  Google Scholar 

  90. Faggioli GL, Curl GR, Ricotta JJ. The role of carotid screening before coronary artery bypass. J Vasc Surg 1990; 12: 724 - 731.

    Article  PubMed  CAS  Google Scholar 

  91. John R, Choudhri AF, Weinberg AD, Ting W, Rose EA, Smith CR, et al. Multicenter review of preoperative risk factors for stroke after coronary artery bypass grafting. Ann Thorac Surg 2000; 69: 30 - 35.

    Article  PubMed  CAS  Google Scholar 

  92. Ricotta JJ, Faggioli GL, Castilone A, Hassett JM. Risk factors for stroke after cardiac surgery: Buffalo Cardiac-Cerebral Study Group. J Vasc Surg 1995; 21: 359 - 364.

    Article  PubMed  CAS  Google Scholar 

  93. Wolman RL, Nussmeier NA, Aggarwal A, Kanchuger MS, Roach GW, Newman MF, et al. Cerebral injury after cardiac surgery: identification of a group at extraordinary risk. Stroke 1999; 30: 514 - 522.

    Article  PubMed  CAS  Google Scholar 

  94. Svedjeholm R, Hakanson E, Szabo Z, Vanky F. Neurological injury after surgery for ischemic heart disease: risk factors, outcome and role of metabolic interventions. Eur J Cardiothorac Surg 2001; 19: 611 - 618.

    Article  PubMed  CAS  Google Scholar 

  95. van Dijk D, Keizer AMA, Diephuis JC, Durand C, Vos LJ, Hijman R. Neurocognitive dysfunction after coronary artery bypass surgery: a systematic review. J Thorac Cardiovasc Surg 2000; 120: 632 - 639.

    Article  PubMed  Google Scholar 

  96. Newman MF, Kirchner JL, Phillips-Bute B, Gaver V, Grocott H, Jones RH, et al., for The Neurological Outcome Research Group and the Cardiothoracic Anesthesiology Research Endeavors Investigators. Longitudinal assessment of neurocognitive function after coronary-artery bypass surgery. N Engl J Med 2001; 344: 395 - 402.

    Article  PubMed  CAS  Google Scholar 

  97. Tuman KJ, McCarthy RI, Najafi H, Ivankovich AD. Differential effects of advanced age on neurological and cardiac risks of coronary artery operations. J Thorac Cardiovasc Surg 1992; 104: 1510 - 1517.

    PubMed  CAS  Google Scholar 

  98. Almassi GH, Sommers T, Moritz TE, Shroyer ALW, London MJ, Henderson WG, et al. Stroke in cardiac surgical patients: determinants and outcome. Ann Thorac Surg 1999; 68: 391 - 397.

    Article  PubMed  CAS  Google Scholar 

  99. Stamou SC, Hill PC, Dangas G, Pfister AJ, Boyce SW, Dullum MKC, et al. Stroke after coronary artery bypass: incidence, predictors, and clinical outcome. Stroke 2001; 32: 1508 - 1513.

    Article  PubMed  CAS  Google Scholar 

  100. Puskas JD, Winston AD, Wright CE, Gott JP, Brown WM, Craver JM, et al. Stroke after coronary artery operation: incidence, correlates, outcome, and cost. Ann Thorac Surg 2000; 69: 1053 - 1056.

    Article  PubMed  CAS  Google Scholar 

  101. Beall AC Jr, Jones JW, Guinn GA, Svensson LG, Nahas C. Cardiopulmonary bypass in patients with previously completed stroke. Ann Thorac Surg 1993; 55: 1383 - 1385.

    Article  PubMed  Google Scholar 

  102. Redmond JM, Greene PS, Goldsborough MA, et al. Neurological injury in cardiac surgical patients with a history of stroke. Ann Thorac Surg 1996; 61: 42 - 47.

    Article  PubMed  CAS  Google Scholar 

  103. Rorick MB, Furlan AJ. Risk of cardiac surgery in patients with prior stroke. Neurology 1990; 40: 835 - 837.

    Article  PubMed  CAS  Google Scholar 

  104. Roach GW, Kanchuger M, Mangano CM, Newman M, Nussmeier N, Wolman R, et al., The Multicenter Study of Perioperative Ischemia Research Group and the Ischemia Research and Education Foundation Investigators. Adverse cerebral outcomes after coronary bypass surgery. N Engl J Med 1996; 335: 1857 - 1864.

    Article  PubMed  CAS  Google Scholar 

  105. McKhann GM, Borowicz LM, Goldsborough MA, Enger C, Selnes OA. Depression and cognitive decline after coronary artery bypass grafting. Lancet 1997; 349: 1282 - 1284.

    Article  PubMed  CAS  Google Scholar 

  106. Breslau PJ, Fell G, Ivey TD, Bailey TD, MillerDW, Strandness DE. Carotid arterial disease in patients undergoing coronary artery bypass operations. J Thorac Cardiovasc Surg 1981; 82: 765 - 767.

    PubMed  CAS  Google Scholar 

  107. Gerraty RP, Gates PC, Doyle JC. Carotid stenosis and perioperative stroke risk in symptomatic and asymptomatic patients undergoing vascular or coronary surgery. Stroke 1993; 24: 1115 - 1118.

    Article  PubMed  CAS  Google Scholar 

  108. Brenner BJ, Bried DK, Alpert A, Goldenkranz RJ, Parsonnet V. The risk of stroke in patients with asymptomatic carotid stenosis undergoing cardiac surgery: a follow-up study. J Vasc Surg 1987; 5: 269 - 279.

    Google Scholar 

  109. Hogue CW Jr, Murphy SF, Schechtman KB, Davila-Roman VG. Risk factors for early or delayed stroke after cardiac surgery. Circulation 1999; 100: 642 - 647.

    Article  PubMed  Google Scholar 

  110. Fruitman DS, MacDougall CE, Ross DB. Cardiac surgery in octogenarians: can elderly patients benefit? Quality of life after cardiac surgery. Ann Thorac Surg 1999; 68: 2129 - 2135.

    Article  PubMed  CAS  Google Scholar 

  111. Wareing TH, Davila-Roman VG, Daily BB, et al. Strategy for the reduction of stroke incidence in cardiac surgical patients. Ann Thorac Surg 1993; 55: 1400 - 1408.

    Article  PubMed  CAS  Google Scholar 

  112. Katz ES, Tunick PA, Rusinek H, Ribakove G, Spencer FC, Kronzon I. Protruding aortic atheromas predict stroke in elderly patients undergoing cardiopulmonary bypass: experience with intraoperative transesophageal echocardiography. J Am Coll Cardiol 1992; 20: 70 - 77.

    Article  PubMed  CAS  Google Scholar 

  113. Borger MA, Ivanov J, Weisel RD, Rao V, Peniston CM. Stroke during coronary bypass surgery: principal role of cerebral macroemboli. Eur J Cardiothorac Surg 2001; 19: 627 - 632.

    Article  PubMed  CAS  Google Scholar 

  114. Moody DM, Bell MA, Chall VR, et al. Emboli occur at the initiation of bypass and during aortic cross-clamping and release brain microemboli during cardiac surgery or aortography. Ann Neurol 1990; 28: 477 - 486.

    Article  PubMed  CAS  Google Scholar 

  115. Eagle KA, Guyton RA, Davidoff R, Ewy GA, Fonger J, Gardner TJ, et al. ACC/AHA guidelines for coronary artery bypass graft surgery: executive summary and recommendations: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1991 Guidelines for Coronary Artery Bypass Graft Surgery). Circulation 1999; 100: 1464 - 1480.

    Article  PubMed  CAS  Google Scholar 

  116. Stump AD, Rorie KD, Jones TJJ. Does off-pump coronary artery bypass surgery reduce the risk of brain injury? Heart Surg Forum. 2001; 4 (Suppl 1): S14 - S20.

    PubMed  Google Scholar 

  117. Hart JC, Spooner TH, Pym J, et al. A review of 1,582 consecutive Octopus off-pump coronary bypass patients. Ann Thorac Surg 2000; 70: 1017 - 1020.

    Article  PubMed  CAS  Google Scholar 

  118. van Dijk D, Nierich AP, Jansen EWL, Nathoe HM, Suyker WJL, Diephuis JC, et al. Early outcome after off-pump versus on-pump coronary bypass surgery: results from a randomized study. Circulation 2001; 104: 1761 - 1766.

    Article  PubMed  Google Scholar 

  119. Rizzo RJ, Whittemore AD, Couper GS, et al. Combined carotid and coronary revascularisation; the preferred approach to the severe vasculopath. Ann Thorac Surg 1992; 54: 1099 - 1108.

    Article  PubMed  CAS  Google Scholar 

  120. Das SK, Brow TD, Pepper J. Continuing controversy in the management of concomitant coronary and carotid disease: an overview. Int J Cardiol 2000; 74: 47 - 65.

    Article  PubMed  CAS  Google Scholar 

  121. Schwartz LB, Bridgman AH, Kieffer RW, et al. Asymptomatic carotid stenosis and stroke in patients undergoing cardiopulmonary bypass. J Vasc Surg 1995; 21: 146 - 153.

    Article  PubMed  CAS  Google Scholar 

  122. Salasidis GC, Latter DA, Steinmetz OK, Blair J, Graham AM. Carotid artery duplex scanning in preoperative assessment for coronary artery revascularisation. J Vasc Surg 1995; 21: 154 - 161.

    Article  PubMed  CAS  Google Scholar 

  123. Gott JP, Thourani VH, Wright CE, Brown WM, Adams AB, Skardasis GM, et al. Risk neutralization in cardiac operations: detection and treatment of associated carotid disease. Ann Thorac Surg 1999; 68: 850 - 856.

    Article  PubMed  CAS  Google Scholar 

  124. Youssuf AM, Karanam R, Prendergast T, Brener B, Hertz S, Saunders CR, et al. Combined off-pump myocardial revascularization and carotid endarterectomy: early experience. Ann Thorac Surg 2001; 72: 1542 - 1545.

    Article  PubMed  CAS  Google Scholar 

  125. Johnsson P, Algotsson L, Ryding E, Stahl E, Messeter K. Cardiopulmonary perfusion and cerebral blood flow in bilateral carotid artery disease. Ann Thorac Surg 1991; 51: 579 - 584.

    Article  PubMed  CAS  Google Scholar 

  126. Hise JH, Nipper ML, Schnitkev JC. Stroke associated with coronary artery bypass grafting. Am J Neuroradiol 1991; 12: 811 - 814.

    PubMed  CAS  Google Scholar 

  127. Riles TS, Kopelman I, Imparato AM. Myocardial infarction following carotid endarterectomy: a review of 683 operations. Surgery 1979; 85: 249 - 253.

    PubMed  CAS  Google Scholar 

  128. Benavente O, Eliasziw M, Streifler JY, Fox AJ, Barnett HJM, Meldrum H, the North American Symptomatic Carotid Endarterectomy Trial Collaborators. Prognosis after Transient Monocular Blindness Associated with Carotid-Artery Stenosis. N Engl J Med 2001; 345: 1084 - 1090.

    Article  PubMed  CAS  Google Scholar 

  129. Grubb RL Jr, Derdeyn CP, Fritsch SM, Carpenter DA, Yundt KD, Videen TO, et al. Importance of hemodynamic factors in the prognosis of symptomatic carotid occlusion. JAMA 1998; 280: 1055 - 1060.

    Article  PubMed  Google Scholar 

  130. Kase CS, Pessin MS, Zivin JA, del Zoppo GJ, Furlan AJ, Buckley JW, et al. Intracranial hemorrhage after coronary thrombolysis with tissue plasminogen activator. Am J Med 1992; 92: 384 - 390.

    Article  PubMed  CAS  Google Scholar 

  131. Gebel JM, Sila CA, Sloan MA, Granger CB, Mahaffey KW, Weisenberger J, et al. Thrombolysisrelated intracranial hemorrhage: a radiographic analysis of 244 cases from the GUSTO-1 trial with clinical correlation. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries. Stroke 1998; 29: 563 - 569.

    Article  PubMed  CAS  Google Scholar 

  132. Sloan MA, Sila CA, Mahaffey KW, Granger CB, Longstreth WT Jr, Koudstaal P, et al. Prediction of 30-day mortality among patients with thrombolysis-related intracranial hemorrhage. Circulation 1998; 98: 1376 - 1382.

    Article  PubMed  CAS  Google Scholar 

  133. Leblanc R, Haddad G, Robitaille Y. Cerebral hemorrhage from amyloid angiopathy and coronary thrombolysis. Neurosurgery 1992; 31: 586 - 590.

    Article  PubMed  CAS  Google Scholar 

  134. Albers GW, Bates VE, Clark WM, Bell R, Verro P, Hamilton SA. Intravenous tissue-type plasminogen activator for treatment of acute stroke: the Standard Treatment with Alteplase to Reverse Stroke (STARS) study. JAMA 2000; 283: 1145 - 1150.

    Article  PubMed  CAS  Google Scholar 

  135. The NINDS t-PA Stroke Study Group. Generalized efficacy oft-PA for acute stroke. Subgroup analysis of the NINDS t-PA Stroke Trial. Stroke 1997; 28: 2119 - 2125.

    Article  Google Scholar 

  136. Scandinavian Simvastatin Survival Study Group: randomized trial of cholesterol-lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet 1994; 344:1383-1389.

    Google Scholar 

  137. Sacks FM, Pfeffer MA, Moye LA, et al. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial Investigators. N Engl J Med 1996; 335: 1001 - 1009.

    Article  PubMed  CAS  Google Scholar 

  138. The Long-Term Intervention with Pravastatin in Ischaemic Disease (LIPID) Study Group. Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels. N Engl J Med 1998; 339: 1349 - 1357.

    Article  Google Scholar 

  139. Downs JR, Clearfield M, Weis S, Whitney E, Shapiro DR, Beere PA, et al., for the AFCAPS/TexCAPS Research Group. Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. JAMA 1998; 279: 1615 - 1622.

    Article  PubMed  CAS  Google Scholar 

  140. Hess DC, Demchuk AM, Brass LM, Yatsu FM. HMG-CoA reductase inhibitors (statins). A promising approach to stroke prevention. Neurology 2000; 54: 790 - 796.

    Article  PubMed  CAS  Google Scholar 

  141. Alberts MJ. Suppression of recurrent transient ischemic attacks by a statin agent. Neurology 2001; 56: 531 - 532.

    Article  PubMed  CAS  Google Scholar 

  142. Rosenberg RD, Aird WC. Vascular-bed-specific hemostasis and hypercoagulable states. N Engl J Med 1999; 340: 1555 - 1564.

    Article  PubMed  CAS  Google Scholar 

  143. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001; 285: 2486 - 2497.

    Article  Google Scholar 

  144. Albers GW. Choice of endpoints in antiplatelet trials. Which outcomes are most relevant to stroke patients ? Neurology 2000; 54: 1022 - 1028.

    Article  PubMed  CAS  Google Scholar 

  145. Steering Committee of the Physicians’ Health Study Research Group. Final report on the aspirin component of the ongoing Physicians’ Health Study. N Engl J Med 1989; 321: 129 - 135.

    Article  Google Scholar 

  146. Manson JE, Stampfer MJ, Colditz GA, et al. A prospective study of aspirin use and primary prevention of cardiovascular disease in women. JAMA 1991; 266: 521 - 527.

    Article  PubMed  CAS  Google Scholar 

  147. Peto R, Gray R, Collins R, et al. Randomised trial of prophylactic daily aspirin in British male doctors. Br Med J 1988; 296: 313 - 316.

    Article  CAS  Google Scholar 

  148. Sanmuganathan PS, Ghahramani P, Jackson PR, Wallis EJ, Ramsay LE. Aspirin for primary prevention of coronary heart disease: safety and absolute benefit related to coronary risk derived from meta-analysis of randomised trials. Heart 2001; 85: 265 - 271.

    Article  PubMed  CAS  Google Scholar 

Download references

Authors
  1. Mitchell S. V. Elkind MD, MS
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Division of Cardiothoracic Surgery, Columbia University College of Physicians and Surgeons, New York, NY, USA

    Niloo M. Edwards MD

  2. Division of Circulatory Physiology/Department of Medicine, Columbia University College of Physicians and Surgeons, New York, NY, USA

    Mathew S. Maurer MD

  3. University of Connecticut School of Medicine, Farmington, CT, USA

    Rachel B. Wellner BA, MPH

Rights and permissions

Reprints and permissions

Copyright information

© 2003 Humana Press Inc., Totowa, NJ

About this chapter

Cite this chapter

Elkind, M.S.V. (2003). Neurological Aspects of Caring for the Aged. In: Edwards, N.M., Maurer, M.S., Wellner, R.B. (eds) Aging, Heart Disease, and Its Management. Contemporary Cardiology. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-59259-357-6_6

Download citation

  • DOI: https://doi.org/10.1007/978-1-59259-357-6_6

  • Publisher Name: Humana Press, Totowa, NJ

  • Print ISBN: 978-1-4684-9766-3

  • Online ISBN: 978-1-59259-357-6

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation